nomifensine has been researched along with Amyotrophic Neuralgia in 1 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Obach Benach, J | 1 |
| Gómez Martínez, G | 1 |
| Vallvé Leal, C | 1 |
| Barceló, P | 1 |
1 other study available for nomifensine and Amyotrophic Neuralgia
| Article | Year |
|---|---|
[Double blind antidepressive (nomifensin) therapeutic test in myotensive cervical syndrome].
Topics: Adult; Brachial Plexus Neuritis; Double-Blind Method; Drug Evaluation; Female; Humans; Isoquinolines | 1980 |